|
1
|
Zuo TT, Zheng RS, Zeng HM, Zhang SW and
Chen WQ: Female breast cancer incidence and mortality in China,
2013. Thorac Cancer. 8:214–218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng R, Zeng H, Zhang S, Chen T and Chen
W: National estimates of cancer prevalence in China, 2011. Cancer
Lett. 370:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Genome Atlas Network: Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Conn SJ, Pillman KA, Toubia J, Conn VM,
Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and
Goodall GJ: The RNA binding protein quaking regulates formation of
circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
You X, Vlatkovic I, Babic A, Will T,
Epstein I, Tushev G, Akbalik G, Wang M, Glock C, Quedenau C, et al:
Neural circular RNAs are derived from synaptic genes and regulated
by development and plasticity. Nat Neurosci. 18:603–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guarnerio J, Bezzi M, Jeong JC, Paffenholz
SV, Berry K, Naldini MM, Lo-Coco F, Tay Y, Beck AH and Pandolfi PP:
Oncogenic Role of Fusion-circRNAs derived from cancer-associated
chromosomal translocations. Cell. 165:289–302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Q, Zhang X, Hu X, Dai L, Fu X, Zhang J
and Ao Y: Circular RNA related to the chondrocyte ECM regulates
MMP13 expression by functioning as a miR-136 ‘Sponge’ in human
cartilage degradation. Sci Rep. 6:225722016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao JT, Zhao SH, Liu QP, Lv MQ, Zhou DX,
Liao ZJ and Nan KJ: Over-expression of circRNA 100876 in non-small
cell lung cancer and its prognostic value. Pathol Res Pract.
213:453–456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li RK, Zhao WY, Fang F, Zhuang C, Zhang
XX, Yang XM, Jiang SH, Kong FZ, Tu L, Zhang WM, et al: Lysyl
oxidase-like 4 (LOXL4) promotes proliferation and metastasis of
gastric cancer via FAK/Src pathway. J Cancer Res Clin Oncol.
141:269–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao J, Xu W, Wang J, Wang K and Li P: The
role and molecular mechanism of Non-Coding RNAs in pathological
cardiac remodeling. Int J Mol Sci. 18:E6082017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soreq H: Novel roles of non-coding brain
RNAs in health and disease. Front Mol Neurosci. 7:552014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Y, Du Y, Liu X and Cho WC:
Involvement of Non-coding RNAs in the signaling pathways of
colorectal cancer. Adv Exp Med Biol. 937:19–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou LD and Zhang J: Circular RNAs: An
emerging type of RNA in cancer. Int J Immunopathol Pharmacol.
30:1–6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Sempere LF, Ouyang H, Memoli VA,
Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, et al:
MicroRNA-31 functions as an oncogenic microRNA in mouse and human
lung cancer cells by repressing specific tumor suppressors. J Clin
Invest. 120:1298–1309. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang
Y, Yee AY, Li M, Du WW, Shatseva T and Yang BB: Expression of
versican 3′-untranslated region modulates endogenous microRNA
functions. PLoS One. 5:e135992010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Wu J, Guan H, Cai J, Fang L, Li J
and Li M: miR-136 promotes apoptosis of glioma cells by targeting
AEG-1 and Bcl-2. FEBS Lett. 586:3608–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan M, Li X, Tong D, Han C, Zhao R, He Y
and Jin X: miR-136 suppresses tumor invasion and metastasis by
targeting RASAL2 in triple-negative breast cancer. Oncol Rep.
36:65–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martin MD and Matrisian LM: The other side
of MMPs: Protective roles in tumor progression. Cancer Metastasis
Rev. 26:717–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh
EJ and Lin SR: MMP13 is potentially a new tumor marker for breast
cancer diagnosis. Oncol Rep. 22:1119–1127. 2009.PubMed/NCBI
|
|
28
|
Zhang B, Cao X, Liu Y, Cao W, Zhang F,
Zhang S, Li H, Ning L, Fu L, Niu Y, et al: Tumor-derived matrix
metalloproteinase-13 (MMP-13) correlates with poor prognoses of
invasive breast cancer. BMC Cancer. 8:832008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shah M, Huang D, Blick T, Connor A, Reiter
LA, Hardink JR, Lynch CC, Waltham M and Thompson EW: An
MMP13-selective inhibitor delays primary tumor growth and the onset
of tumor-associated osteolytic lesions in experimental models of
breast cancer. PLoS One. 7:e296152012. View Article : Google Scholar : PubMed/NCBI
|
